Several recent reviews explore the links between obesity, insulin resistance and the metabolic syndrome, and cancer [65,66,67,68] highlighting the potential roles of hyperinsulinaemia, higher bioactivity of IGF-I, IGF-II and insulin through IR-A and IGF1R. The gene discussed is IGF2; the disease is obesity disorder.